Tobacco use is the leading cause of preventable disease, disability, and death in the United States. Each year, nearly half a million Americans die prematurely of smoking or exposure to secondhand smoke and 16 million live with a serious illness caused by smoking. Smoking can cause repairable damage to various organs including the heart, lungs, kidneys, stomach and intestines. Smoking is associated with the causation of various cancers in the humans. Quitting smoking cuts cardiovascular risks, reduces risk for stroke to about half that of a nonsmoker’s, reduces risks for cancers of the mouth, throat, esophagus, and bladder by half within 5 years and ten years after quitting smoking, the risk for lung cancer drops by half. Smoking cessation can be achieved by some general, non-pharmacological and pharmacological strategies.
Tobacco use is the leading cause of preventable disease, disability, and death in the United States, accounting for more than 480,000 deaths every year, or 1 of every 5 deaths.[1]
In 2015, about 15 of every 100 U.S. adults aged 18 years or older (15.1%) currently smoked cigarettes, this means an estimated 36.5 million adults in the United States currently smoke cigarettes.
Current smoking has declined from nearly 21 of every 100 adults (20.9%) in 2005 to about 15 of every 100 adults (15.1%) in 2015.
Nearly 40 million US adults still smoke cigarettes, and about 4.7 million middle and high school students use at least one tobacco product, including e-cigarettes.
Every day, more than 3,800 youth younger than 18 years smoke their first cigarette.
Each year, nearly half a million Americans die prematurely of smoking or exposure to secondhand smoke and more than 16 million Americans live with a smoking-related disease.
Each year, the United States spends nearly $170 billion on medical care to treat smoking-related disease in adults.
The epidemiology of the current smoking status based on different descriptive characteristics is as follows:
Smoking harms nearly every organ of the body and affects a person’s overall health.Smoking can make it harder for a woman to become pregnant. It can also affect her baby’s health before and after birth. Smoking increases risks for:
Women past childbearing years who smoke have weaker bones than women who never smoked. They are also at greater risk for broken bones.
Smoking affects the health of your teeth and gums and can cause tooth loss.
Smoking can increase your risk for cataracts (clouding of the eye’s lens that makes it hard for you to see). It can also cause age-related macular degeneration (AMD). AMD is damage to a small spot near the center of the retina, the part of the eye needed for central vision.
Smoking is a cause of type 2 diabetes mellitus and can make it harder to control. The risk of developing diabetes is 30–40% higher for active smokers than nonsmokers.
Smoking causes general adverse effects on the body, including inflammation and decreased immune function.
The 5As are an evidence-based framework for structuring smoking cessation in health care settings. The 5As include: Ask, Assess, Advise, Assist and Arrange follow-up.
The 5As
Technique
Ask
Identify and document tobacco use status for every patient at every visit
Advise
In a clear, strong, and personalized manner, urge every tobacco user to quit.
Advices should be:
Clear:
I think it is important for you to quit smoking now and I can help you. Cutting down while you are ill is not enough.
Strong:
As your clinician, I need you to know that quitting smoking is the most important thing you can do to protect your health now and in the future. The clinic staff and I will help you.
Personalized:
Tie tobacco use to current health, and its social and economic costs, motivation level to quit, and the impact of tobacco use on children and others in the household.
Assess
Assess willingness to make a quit attempt.
Is the tobacco user willing to make a quit attempt within the next 30 days?
Assist
For the patient willing to make a quit attempt, offer medication and provide or refer for counseling or additional treatment to help the patient quit.
For patients unwilling to quit at the time, provide interventions designed to increase future quit attempts.
Arrange follow-up
For the patient willing to make a quit attempt, arrange for followup contacts, beginning within the first week after the quit date.
For patients unwilling to make a quit attempt at the time, address tobacco dependence and willingness to quit at next clinic visit.
First-line pharmacotherapy includes the multiple forms of nicotine replacement therapy (patch, nasal spray, losenge, gum, inhaler), sustained- release bupropion hydrochloride, and varenicline. Second line therapy includes clonidine and nortriptyline and have been found to be efficacious.[6] The following is a description of the various treatment modalities available:[7]